Catherine Davidson - Hemagen Diagnostics Insider

Hemagen Diagnostics Inc -- USA Stock  

USD 0.01  0.00  0.00%

Principal Financial Officer, Principal Accounting Officer and Controller

Mrs. Catherine M. Davidson serves as Principal Accounting Officer, Controller of Hemagen Diadnostics, Inc. Mrs. Davidson was appointed Controller of Hemagen in April 2007. Prior to her appointment, Mrs. Davidson served as CFO of Pepco Building Services, Inc. On July 11, 2007, Catherine Davidson was appointed as the Companys Principal Financial Officer and Principal Accounting Officer. For the five years prior to joining Hemagen, Mrs. Davidson served as the Chief Financial Officer of Pepco Building Services, Inc., overseeing the finance and accounting functions of that company and its subsidiaries.
Age: 46  Executive Since 2013      

Management Efficiency

The company has return on total asset (ROA) of (10.27) % which means that it has lost $10.27 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (80.2) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 5.03 M in liabilities. Hemagen Diagnostics Inc has Current Ratio of 1.05 suggesting that it is not liquid enough and may have problems to pay out its financial obligations when they are due.

Similar Executives

Entity Summary

Hemagen Diagnostics, Inc., a biotechnology company, provides human and veterinary clinical diagnostic solutions worldwide. The company was founded in 1985 and is based in Columbia, Maryland. Hemagen Diagnostics operates under Biotechnology classification in USA and traded on OTC Market exchange. It employs 15 people.Hemagen Diagnostics Inc (HMGN) is traded on OTC Market in USA. It is located in 9033 Red Branch Road and employs 15 people.

Did you try this?

Run Watchlist Optimization Now

Watchlist Optimization

Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Hide  View All  NextLaunch Watchlist Optimization
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Hemagen Diagnostics Inc to your portfolio

Top Management

Hemagen Diagnostics Inc Leadership Team
William Hales, Chairman
Robert Campbell, CFO
Catherine Davidson, Executive
Edward Lutz, Director, MBA
Alan Cohen, Director

Stock Performance

Hemagen Diagnostics Performance Indicators